Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.
Fabian CJ, Mudaranthakam DP, Gajewski B, Young K, Winblad O, Khan SA, Garber JE, Esserman LJ, Yee LD, Nye L, Powers KR, Ranallo L, Kreutzjans AL, Pittman K, Altman C, Metheny T, Zelenchuk A, Komm BS, Kimler BF.
Fabian CJ, et al. Among authors: khan sa.
Contemp Clin Trials. 2024 Sep 16:107697. doi: 10.1016/j.cct.2024.107697. Online ahead of print.
Contemp Clin Trials. 2024.
PMID: 39293780